| Literature DB >> 27806729 |
Aregawi Yalew1, Betelihem Terefe1, Meseret Alem2, Bamlaku Enawgaw3.
Abstract
BACKGROUND: Hematological reference values are important for the clinical decisions in laboratory diagnosis and monitoring of patients. The correct interpretation of laboratory results depends entirely on the reference intervals that have been established for the locality. But, in sub-Saharan African countries particularly in Ethiopia, locally derived reference intervals were not established and they are forced to use intervals established from western population. Thus this study aimed to establish locally derived hematological reference values that could be used in Northwest Ethiopia.Entities:
Keywords: Adult population; Gondar; Hematological reference interval
Mesh:
Substances:
Year: 2016 PMID: 27806729 PMCID: PMC5093958 DOI: 10.1186/s13104-016-2288-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Result of Harris and Boyd test, which was performed to see the need for partitioning of Reference interval based on sex
| Parameters | P value | Harris and Boyd | ||
|---|---|---|---|---|
| Z* | Z† | Decision | ||
| WBC (×109/l) | 0.3779 | 3 | 0.4 | No separate RI |
| Neutrophil (%) | 0.7239 | 3 | 0.6 | No separate RI |
| Neutrophils absolute (×109/l) | 0.6331 | 3 | 0.01 | No separate RI |
| Lymphocyte (%) | 0.6750 | 3 | 0.5 | No separate RI |
| Lymphocytes absolute (×109/l) | 0.1705 | 3 | 0.9 | No separate RI |
| Mixed (%) | 0.5375 | 3 | 0.5 | No separate RI |
| Mixed absolute (×109/l) | 0.2784 | 3 | 0.5 | No separate RI |
| Platelet (×109/l) | 0.0223 | 3 | 2.3 | No separate RI |
| RBC (×1012/l) |
| 3 | 3.4 | Separate RI |
| Hgb (g/dl) | < | 3 | 5.6 | Separate RI |
| PCV (%) |
| 3 | 3.4 | Separate RI |
| MCH (pg) |
| 3 | 3.1 | Separate RI |
| MCHC (g/dl) | < | 3 | 5.0 | Separate RI |
| MCV (fl) | 0.2929 | 3 | 0.3 | No separate RI |
| RDW | 0.9577 | 3 | 0.6 | No separate RI |
| ESR (mm/h) | 0.3283 | 3 | 0.9 | No separate RI |
Z† = critical value, Z* = calculated value, Separate RI are needed only when Z† is greater than Z*, P value is derived from Mann–Whitney U test
Italic values indicate hematological parameters which need partition between male and female (Z† > Z*)
The socio demographic characteristics of adult of Gondar participated in the study
| Variables | Socio demographic characteristics | Frequency | Percentage (%) |
|---|---|---|---|
| Sex | Male | 120 | 50 |
| Female | 120 | 50 | |
| Age group (years) | 18–25 | 167 | 69.6 |
| 26–35 | 51 | 21.2 | |
| >35 | 22 | 9.2 | |
| Address | Gondar | 188 | 78.9 |
| Around gondar | 52 | 21.1 | |
| Marital status | Married | 64 | 26.7 |
| Single | 174 | 72.5 | |
| Divorced | 2 | 0.8 | |
| Religion | Orthodox | 214 | 89.2 |
| Muslim | 22 | 9.2 | |
| Protestant | 1 | 0.4 | |
| Others | 3 | 1.2 | |
| Occupation | Civil servant | 21 | 8.8 |
| Private | 36 | 15.0 | |
| House wife | 6 | 2.5 | |
| Farmer | 37 | 15.4 | |
| Students | 120 | 58.3 |
Median, IQR, range and 95th percentile of reference interval, P values of hematological parameters for adult in Gondar, northwestern Ethiopia
| Parameters | N | Median (IQR) | Range (min–max) | RI (95th percentile) | Lower limit 90% CI | Upper limit 90% CI |
|---|---|---|---|---|---|---|
| WBC (×109/l) | 240 | 5.1 (4.2–6.3) | 2.7–9.5 | 3.2–8.8 | 3.2 (2.9–3.5) | 8.8 (8.3–9.1) |
| Neutrophil (%) | 240 | 53 (48–58) | 30–77 | 36–69 | 36 (33.8–39.1) | 69 (66.9–76.5) |
| Neutrophils absolute (×109/l) | 240 | 2.7 (2.1–3.5) | 1.3–7.3 | 1.6–5.1 | 1.6 (1.3–1.7) | 5.1 (4.6–6.2) |
| Lymphocyte (%) | 240 | 38 (33–42) | 17–56 | 22–55 | 22 (18.2–24.9) | 55 (52.4–55.9) |
| Lymphocytes absolute (×109/l) | 240 | 1.9 (1.5–2.3) | 0.70–5.0 | 1–3.5 | 1 (0.8–1.1) | 3.5 (3.2–4.2) |
| Mixed (%) | 240 | 9 (8–11) | 4–18 | 6–13 | 6 (5.4–6.4) | 13 (13.0–18.0) |
| Mixed absolute (×109/l) | 240 | 0.50 (0.4–0.6) | 0.2–1.2 | 0.2–1 | 0.2 (0.2–0.3) | 1.0 (0.9–1.2) |
| MCV (fl) | 240 | 92 (90–94) | 78–105 | 85–100 | 85 (80.3–85.1) | 100 (99–102) |
| Platelet (×109/l) | 240 | 264 (210–312) | 110–531 | 128–432 | 128 (115–140) | 432 (403–496) |
| ESR (mm/h) | 240 | 5.0 (0–5) | 0–20 | 0–15 | 0 (0–0) | 15 (15–20) |
| RDW | 240 | 14 (13–14) | 12–18 | 12–17 | 12 (12–12.7) | 17 (15.5–18.3) |
| RBC (×1012/l) | ||||||
| Male | 120 | 5.01 (4.56–5.59) | 3.12–6.95 | 3.53–6.93 | 3.53 (3.12–3.9) | 6.93 (6.45–6.95) |
| Female | 120 | 4.8 (4.2–5.25) | 3.0–6.50 | 3.45–6.25 | 3.45 (3.0–3.57) | 6.25 (6.08–6.5) |
| Hgb (g/dl) | ||||||
| Male | 120 | 14.2 (13.1–15.5) | 11.0–19.1 | 11.5–18.0 | 11.5 (11–11.9) | 18.0 (17.9–19.1) |
| Female | 120 | 12.9 (12.0–14.3) | 10.9–16.9 | 11.0–16.7 | 11.0 (10.9–11.3) | 16.7 (16.2–16.9) |
| PCV (%) | ||||||
| Male | 120 | 46.9 (43.2–50.0) | 34.5–60.2 | 36.2–58.6 | 36.2 (34.5–37.6) | 58.6 (57.0–60.2) |
| Female | 120 | 45.2 (40.4–48) | 30.8–59.0 | 32.1–56.6 | 32.1 (30.8–36) | 56.6 (52.1–59) |
| MCH (pg) | ||||||
| Male | 120 | 29.0 (28–30) | 26–34.0 | 26.6–33.3 | 26.6 (25.7–27.1) | 33.3 (32–34) |
| Female | 120 | 28.6 (27.7–29.2) | 25.6–33.1 | 25.8–32.8 | 25.8 (25.6–26.4) | 32.8 (31–33.1) |
| MCHC (g/dl) | ||||||
| Male | 120 | 31.3 (30.6–32.4) | 28.0–36.5 | 29.5–34.4 | 29.5 (28–30) | 34.4 (33.6–36.5) |
| Female | 120 | 30.8 (30.0–31.2) | 28.0–34.7 | 28.5–34.4 | 28.5 (28–29) | 34.4 (32.5–34.7) |
Fig. 1Box and Whisker plots indicating the effect of sex on hematological parameters of the study participants. a Red blood cells, b Hemoglobin, c Hematocrit, d Mean corpuscular hemoglobin, e Mean corpuscular hemoglobin concentration
Comparison of median, 95% reference range and Mean ± SD of hematological parameters in this study and others
| Parameter | Gondar (current study) | Addis Ababa [ | Kenya [ | Burkina Faso (22) | Wintrobe [ | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | |
| WBC (×109) | Female | 5.1 (3.2–8.8) | 5.3 ± 1.4 | 5.9 (3–12.2) | 6.2 ± 2.2 | 4.9 (3.0–9.1) | NA | 5.2 (3.4–7.4) | NA | NA (4.3–10) | 7.2 ± NA |
| Male | 5.9 (3–9.8) | 6.0 ± 1.8 | 4.3 (2.7–7.5) | NA | 5.1 (3.2–9.2) | NA | NA (4.3–100) | 7.2 ± NA | |||
| Platelet (×109) | Female | 264 (128–432) | 267 ± 76 | 193 (98–352) | 202 ± 67 | 251 (124–444) | NA | 252 (159–356) | NA | NA (150–450) | NA |
| Male | 203 (97–324) | 207 ± 62 | 218 (115–366) | NA | 217 (127–365) | NA | NA (150–450) | NA | |||
| Neutrophil (absolute) (×109) | Female | 2.7 (1.6–5.1) | 2.8 ± 0.9 | NA | NA | 1.96 (0.99–5.6) | NA | NA | NA | NA | NA |
| Male | NA | NA | 1.78 (0.88–4.3) | NA | NA | NA | NA | NA | |||
| Neutrophil (%) | Female | 53 (36–69) | 53 ± 8 | NA | NA | 42 (20–70) | NA | 46 (30–62) | NA | NA | NA |
| Male | NA | NA | 42 (20–70) | NA | 43 (27–64) | NA | NA | NA | |||
| Lymphocyte (absolute) (×109) | Female | 1.9 (1–3.5) | 2 ± 0.7 | 1.7 (1.09–3.5) | NA | 2.16 (1.29–4.0) | NA | 2.2 (1.4–3.2) | NA | NA | NA |
| Male | (0.96–3.5) | NA | 1.86 (1.12–3.2) | NA | 2.1 (1.3–4.0) | NA | NA | NA | |||
| Lymphocyte (%) | Female | 38 (22–55) | 37 ± 8 | (17–59) | 36 ± NA | 45 (20–60) | NA | 43 (27–57) | NA | NA | NA |
| Male | (17–59) | 36 ± NA | 45 (20–60) | NA | 44 (26–60) | NA | NA | NA | |||
| Mix cells (absolute) (×109) | Female | 0.5 (0.2–1) | 0.5 ± 0.2 | NA | NA | NA | NA | NA | NA | NA | NA |
| Male | NA | NA | NA | NA | NA | NA | NA | NA | |||
| Mixed cells (%) | Female | 9 (6–13) | 10 ± 2 | NA | NA | NA | NA | NA | NA | NA | NA |
| Male | NA | NA | NA | NA | NA | NA | NA | NA | |||
WBC white blood cells, SD standard deviation, NA not applicable
Comparison of median, 95% reference range and Mean ± SD of hematological parameters in this study and others
| Parameter | Gondar (current study) | Addis Ababa [ | Kenya [ | Burkina Faso (22) | Wintrobe [ | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | |
| RBC (×1012) | ||||||||||
| Female | 4.8 (3.45–6.25) | 4.7 ± 0.725 | 4.5 (3.7–5.2) | 4.5 ± 0.4 | 4.8 (3.7–5.6) | NA | 4.2 (3.5–4.9) | NA | NA (4.2–5.5) | 4.8 ± NA |
| Male | 5.01 (3.53-6.93) | 0.09 ± 0.79 | 5 (4.3–5.9) | 5.1 ± 0.4 | 5.3 (4.4–6.3) | NA | 4.7 (3.8–5.6) | NA | NA (4.5–6.3) | 5.4 ± NA |
| PCV (%) | ||||||||||
| Female | 45.2 (32.1–56.6) | 44.2 ± 5.84 | 42.1 (35.3–48.8) | 42 ± 3.2 | 40 (30–50) | NA | 35 (30–39) | NA | NA (37–47) | 42 ± NA |
| Male | 46.9 (36.2–58.6) | 6.8 ± 5.8 | 48.2 (41.6–55.11) | 48.3 ± 3.7 | 47 (40–50) | NA | 39 (34–46) | NA | NA (41–51) | 46 ± NA |
| Hgb (g/dl) | ||||||||||
| Female | 12.9 (11–16.7) | 13.2 ± 1.6 | 14.9 (12.2–16.6) | 14.3 ± 3.4 | 8.44 (5.9–10) | NA | 12 (9.8–13.5) | NA | NA (12–16) | 14 ± NA |
| Male | 14.2 (11.5–18) | 14.4 ± 1.8 | 16.1 (13.9–18.3) | 16.1 ± 1.1 | 9.9 (8.3–11.3) | NA | 13.5 (11.3–15.6) | NA | NA (14–18) | 16 ± NA |
| MCV (fl | ||||||||||
| Female | 92 ± 3.7 | NA | NA | 84.9 (66–95.7) | NA | 84 (75–92) | NA | NA | NA | |
| Male | 92 (85 –100) | NA | NA | 88 (71.4–98.2) | NA | 85 (73–94) | NA | NA | NA | |
| MCH (pg) | ||||||||||
| Female | 28.6 (25.8–32.8) | 28.5 ± 1.46 | NA | NA | NA | NA | 28 (24–32) | NA | NA | NA |
| Male | 29 (26.6–33.3) | 29.1 ± 1.54 | NA | NA | NA | NA | 29 (25–34) | NA | NA | NA |
| MCHC (g/dl) | ||||||||||
| Female | 30.8 (28.5–34.4) | 30.6 ± 1.2 | NA | NA | 33.9 (32.2–35.2) | NA | 34.2 (31.4–36.1) | NA | NA | NA |
| Male | 31.3 (29.5–34.4) | 31.5 ± 1.3 | NA | NA | 34.2 (32.4–35.3) | NA | 34.6 (31.7–36.3) | NA | NA | NA |
Comparisons of median and 95% reference range with Eastern and Southern Africa (18), Tanzania (19), Togo (20) and Uganda (21) of African countries
| Parameters | Gondar | Togo | Tanzania | Uganda | Eastern and southern Africa |
|---|---|---|---|---|---|
| Median (95% range) | Median (95% range) | Median (95% range) | Median (95% range) | Median (95% range) | |
| WBC (×109/l) | 5.1 (3.2–8.8) | 4.1 (1.9–10.1) | 4.6 (3.0–7.9) | 4.9 (2.8–8.2) | 3.1–9.1 |
| Neutrophils (Abs) | 2.7 (1.6–5.1) | 1.6 (0.5–5.4) | 2.2 (1.1–4.7) | NA | 1.0–5.3 |
| Neutrophils (%) | 53 (36–69) | NA | 48.1 (32.0–69.1) | 38.9 (22.2–59.3) | 25–66 |
| Lymphocyte (Abs) | 1.9 (1–3.5) | 2.1 (1.1–4.3) | 1.8 (1.1–3.0) | NA | 1.2–3.7 |
| Lymphocyte (%) | 38 (22–55) | NA | 40.5 (20.8–56.7) | 44.4 (26.7–61.2) | 23–59 |
| Mixed (Abs) | 0.5 (0.2–1) | NA | 0.5 (0.3–1.1) | NA | NA |
| Mixed (%) | 9 (6–13) | NA | 10.3 (5.6–19.8) | NA | NA |
| Platelet (×109/l) | 264 (128–432) | 239 (120–443) | 244 (150–398) | 218.5 (109–384) | 126–438 |
| MCV (fl) | 92 (85–100) | 84.5 (80–99) | 89.4 (77.6–98.1) | 85 (71–97) | 68–98 |
| RBC (×1012/l) | |||||
| Male | 4.8 (3.45–6.25) 5.0 | 5.0 (3.3–6.4) | 5.21 (4.41–6.27) | 5.0 (3.8–6.1) | 4.0–6.4 |
| Female | 1 (3.53–6.93) | 4.5 (3.1–6.0) | 4.69 (3.84–5.59) | 4.4 (3.3–5.3) | 3.8–5.6 |
| Hgb (g/dl) | |||||
| Male | 12.9 (11–16.7) | 15.8 (10.0–18.4) | 15.4 (13.7–17.7) | 14.5 (11.6–17.1) | 12.2–17.7 |
| Female | 14.2 (11.5–18) | 13.0 (10.3–17.1) | 13.5 (11.1–15.7) | 12.8 (9.8–16.2) | 9.5–15.8 |
| PCV (%) | |||||
| Male | 45.2 (32.1–56.6) | 42.8 (28.0–54.0) | 46.6 (40.2–53.7) | 42.6 (33.8–49.5) | 35.0–50.8 |
| Female | 46.9 (36.2–58.6) | 38.1 (28.0–47.0) | 41.5 (36.2–46.8) | 37.8 (28.3–46.8) | 29.4–45.4 |
| MCH (pg) | |||||
| Male | 28.6 (25.8–32.8) | 29.7 (26–36) | 30.0 (23.1–33.2) | 29.2 (23.0–33.8) | NA |
| Female | 29 (26.6–33.3) | 29.3 (25–37) | 29.3 (24.2–33.1) | 29.5 (24.8–32.7) | NA |
| MCHC (%) | |||||
| Male | 30.8 (28.5–34.4) | 35.1 (29–39) | 33.3 (30.6–35.1) | 34.2 (32.4–35.3) | NA |
| Female | 31.3 (29.5–34.4) | 35.1 (30–41) | 32.7 (30.4–34.8) | 34.2 (33.0–35.5) | NA |
| RDW (%) | |||||
| Male | 14 (12–17) | NA | NA | 12.8 (10.9–16.8) | NA |
| Female | 14 (12–17) | NA | NA | 12.7 (11.0–17.3) | NA |
Abs absolute